Antisoma plunges as lung-cancer-drug trial halted By: MarketWatch March 29, 2010 at 05:14 AM EDT Shares of Antisoma skid around 70% on Monday after the British biotech halts a late-stage trial of a lung-cancer drug. Read More >> Related Stocks: Novartis Ag ADR